Sumitomo Mitsui DS Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Hold
24,506
0.01% 531
2026
Q1
$2.22M Buy
24,506
+755
+3% +$69.3K 0.02% 497
2025
Q4
$2.14M Hold
23,751
0.02% 509
2025
Q3
$2.34M Buy
23,751
+582
+3% +$57.7K 0.02% 477
2025
Q2
$2.11M Sell
23,169
-67
-0.3% -$6.48K 0.02% 485
2025
Q1
$2.63M Buy
23,236
+557
+2% +$59.6K 0.03% 428
2024
Q4
$2.4M Buy
22,679
+449
+2% +$48.2K 0.02% 444
2024
Q3
$2.4M Buy
22,230
+337
+2% +$36.8K 0.03% 434
2024
Q2
$2.38M Buy
21,893
+2,881
+15% +$340K 0.03% 409
2024
Q1
$2.51M Buy
19,012
+153
+0.8% +$19.1K 0.03% 401
2023
Q4
$2.3M Buy
18,859
+344
+2% +$38.4K 0.03% 418
2023
Q3
$2.08M Buy
18,515
+108
+0.6% +$13.7K 0.03% 386
2023
Q2
$2.68M Buy
18,407
+2,048
+13% +$278K 0.04% 341
2023
Q1
$2.11M Buy
16,359
+178
+1% +$22.3K 0.04% 353
2022
Q4
$2.06M Buy
16,181
+128
+0.8% +$14.9K 0.04% 348
2022
Q3
$1.68M Buy
16,053
+2,219
+16% +$244K 0.04% 365
2022
Q2
$1.45M Buy
13,834
+837
+6% +$99.3K 0.03% 390
2022
Q1
$1.66M Sell
12,997
-313
-2% -$37.7K 0.04% 381
2021
Q4
$1.64M Sell
13,310
-31
-0.2% -$4.06K 0.03% 411
2021
Q3
$1.9M Sell
13,341
-125
-0.9% -$18.4K 0.04% 344
2021
Q2
$2.1M Sell
13,466
-38
-0.3% -$6.16K 0.05% 313
2021
Q1
$2.1M Buy
13,504
+105
+0.8% +$16.3K 0.06% 298
2020
Q4
$2M Sell
13,399
-97
-0.7% -$13.7K 0.06% 295
2020
Q3
$1.78M Buy
13,496
+153
+1% +$20K 0.06% 281
2020
Q2
$1.55M Sell
13,343
-124
-0.9% -$14.3K 0.05% 290
2020
Q1
$1.32M Buy
13,467
+516
+4% +$67.6K 0.05% 282
2019
Q4
$1.88M Sell
12,951
-132
-1% -$18.2K 0.06% 271
2019
Q3
$1.74M Buy
13,083
+1,638
+14% +$212K 0.06% 277
2019
Q2
$1.31M Sell
11,445
-3,060
-21% -$358K 0.05% 314
2019
Q1
$1.8M Buy
14,505
+830
+6% +$94.3K 0.03% 375
2018
Q4
$1.38M Sell
13,675
-805
-6% -$90.5K 0.02% 388
2018
Q3
$1.85M Sell
14,480
-92
-0.6% -$10.9K 0.03% 380
2018
Q2
$1.58M Buy
14,572
+103
+0.7% +$11.2K 0.02% 409
2018
Q1
$1.53M Sell
14,469
-877
-6% -$102K 0.02% 418
2017
Q4
$1.8M Sell
15,346
-803
-5% -$90.8K 0.03% 389
2017
Q3
$1.83M Buy
16,149
+20
+0.1% +$2.31K 0.03% 350
2017
Q2
$2.01M Sell
16,129
-774
-5% -$91.8K 0.03% 346
2017
Q1
$2M Buy
16,903
+1,649
+11% +$187K 0.03% 347
2016
Q4
$1.53M Sell
15,254
-744
-5% -$79.7K 0.03% 362
2016
Q3
$2.02M Buy
15,998
+626
+4% +$77.3K 0.04% 312
2016
Q2
$1.8M Buy
15,372
+1,037
+7% +$117K 0.05% 283
2016
Q1
$1.48M Buy
14,335
+1,186
+9% +$115K 0.05% 305
2015
Q4
$1.31M Sell
13,149
-69
-0.5% -$6.75K 0.04% 318
2015
Q3
$1.21M Sell
13,218
-291
-2% -$29.2K 0.04% 349
2015
Q2
$1.43M Sell
13,509
-327
-2% -$36.2K 0.05% 344
2015
Q1
$1.58M Sell
13,836
-1,060
-7% -$121K 0.05% 338
2014
Q4
$1.64M Sell
14,896
-1,206
-7% -$127K 0.05% 342
2014
Q3
$1.57M Sell
16,102
-1,108
-6% -$109K 0.05% 361
2014
Q2
$1.74M Sell
17,210
-1,682
-9% -$164K 0.05% 348
2014
Q1
$1.73M Sell
18,892
-1,109
-6% -$102K 0.05% 333
2013
Q4
$1.81M Sell
20,001
-1,117
-5% -$96.7K 0.05% 324
2013
Q3
$1.68M Sell
21,118
-1,846
-8% -$145K 0.05% 340
2013
Q2
$1.67M Buy
+22,964
New +$1.72M 0.05% 344

Other funds holding ZBH

Sumitomo Mitsui DS Asset Management's ZBH Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 24,506 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #531.

Sumitomo Mitsui DS Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.68M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 24,506 shares of Zimmer Biomet worth $2.11M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.01% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #531 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui DS Asset Management's Zimmer Biomet position peaked at $2.68M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.